AI coach aims to ease life after breast cancer

NCT ID NCT07770243

First seen Aug 18, 2026 ยท Last updated Aug 18, 2026

Summary

This pilot trial tests an artificial intelligence-based platform designed to help breast cancer survivors manage lingering symptoms like fatigue, pain, and insomnia after finishing treatment. Thirty-six women who have completed primary treatment within the past two years will be randomly assigned to use the platform or receive usual care. The study will measure whether the platform is practical, acceptable, and helpful in reducing symptom burden and improving quality of life.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
A digital self-management platform that uses artificial intelligence to provide personalized symptom monitoring and support.
What this could lead to
If effective, this AI-driven platform could offer a scalable way to help breast cancer survivors manage symptoms and improve their quality of life after treatment.
What could go wrong
This is a small pilot study focused on feasibility, not proof of effectiveness. The platform may not be acceptable to all users or may not significantly reduce symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.